Biological Response of Trauma Patients to Standard Trauma Resuscitation Therapy
Trial Summary
What is the purpose of this trial?
Overall aim of this work is to evaluate new methods of resuscitation that can be applied by front-line responders on the battlefield, in civilian life, or which can be used during initial resuscitation in the first fixed facility to which the injured patient is brought.
Research Team
Charles Van Way, III, M.D.
Principal Investigator
University of Missouri, Kansas City
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- Glutamine (Other)
- Placebo (Other)
- Ringer's Lactate (Other)
- Standard Trauma Resuscitation Therapy (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri, Kansas City
Lead Sponsor
Donald Jeff Keyser
University of Missouri, Kansas City
Chief Executive Officer since 2017
PhD in Economics from The University of Texas at Dallas
Edwina Baskin-Bey
University of Missouri, Kansas City
Chief Medical Officer
MD from Mount Sinai/NYU School of Medicine
United States Department of Defense
Collaborator
Pete Hegseth
United States Department of Defense
Chief Executive Officer
Bachelor's degree in Political Science from Princeton University, JD from Harvard Law School
Lisa Hershman
United States Department of Defense
Chief Medical Officer since 2021
MD from Uniformed Services University of the Health Sciences